Literature DB >> 26045291

Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets.

Laurence de Leval1, Marie Parrens2, Fabien Le Bras3, Jean-Philippe Jais4, Virginie Fataccioli5, Antoine Martin6, Laurence Lamant7, Richard Delarue8, Françoise Berger9, Flavie Arbion10, Céline Bossard11, Marie-Christine Copin12, Danielle Canioni13, Frédéric Charlotte14, Gandhi Damaj15, Peggy Dartigues16, Bettina Fabiani17, Albane Ledoux-Pilon18, Karine Montagne19, Thierry Molina13, Martine Patey20, Patrick Tas21, Michel Peoch22, Barbara Petit23, Tony Petrella24, Jean-Michel Picquenot25, Thérèse Rousset26, Marie-Christine Rousselet27, Isabelle Soubeyran28, Sylvie Thiebault29, Olivier Tournilhac30, Luc Xerri31, Christian Gisselbrecht32, Corinne Haioun3, Georges Delsol7, Philippe Gaulard33.   

Abstract

Entities:  

Keywords:  France; angioimmunoblastic T-cell lymphoma; epidemiology; peripheral T-cell lymphoma; prevalence

Mesh:

Year:  2015        PMID: 26045291      PMCID: PMC4800690          DOI: 10.3324/haematol.2015.126300

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan.

Authors:  Takashi Tokunaga; Kazuyuki Shimada; Kazuhito Yamamoto; Dai Chihara; Takuji Ichihashi; Rika Oshima; Mitsune Tanimoto; Toshihiro Iwasaki; Atsushi Isoda; Akira Sakai; Hikaru Kobayashi; Kunio Kitamura; Kosei Matsue; Masafumi Taniwaki; Sadahiro Tamashima; Yoshio Saburi; Taro Masunari; Tomoki Naoe; Shigeo Nakamura; Tomohiro Kinoshita
Journal:  Blood       Date:  2012-02-02       Impact factor: 22.113

2.  Efficacy of 5-azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma.

Authors:  Morgane Cheminant; Julie Bruneau; Olivier Kosmider; François Lefrere; Richard Delarue; Philippe Gaulard; Isabelle Radford; Coralie Derrieux; Olivier Hermine; François Lemonnier
Journal:  Br J Haematol       Date:  2014-10-14       Impact factor: 6.998

3.  Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma.

Authors:  A Melnyk; A Rodriguez; W C Pugh; F Cabannillas
Journal:  Blood       Date:  1997-06-15       Impact factor: 22.113

4.  Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.

Authors:  François Lemonnier; Lucile Couronné; Marie Parrens; Jean-Philippe Jaïs; Marion Travert; Laurence Lamant; Olivier Tournillac; Therese Rousset; Bettina Fabiani; Rob A Cairns; Tak Mak; Christian Bastard; Olivier A Bernard; Laurence de Leval; Philippe Gaulard
Journal:  Blood       Date:  2012-07-03       Impact factor: 22.113

5.  Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients.

Authors:  Florence Lachenal; Francoise Berger; Hervé Ghesquières; Pierre Biron; Arnaud Hot; Evelyne Callet-Bauchu; Catherine Chassagne; Bertrand Coiffier; Isabelle Durieu; Hugues Rousset; Gilles Salles
Journal:  Medicine (Baltimore)       Date:  2007-09       Impact factor: 1.889

6.  Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

Authors:  Nathalie Mourad; Nicolas Mounier; Josette Brière; Emmanuel Raffoux; Alain Delmer; Alfred Feller; Chris J L M Meijer; Jean-François Emile; Réda Bouabdallah; André Bosly; Jacques Diebold; Corinne Haioun; Bertrand Coiffier; Christian Gisselbrecht; Philippe Gaulard
Journal:  Blood       Date:  2008-02-21       Impact factor: 22.113

7.  International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

Authors:  Julie Vose; James Armitage; Dennis Weisenburger
Journal:  J Clin Oncol       Date:  2008-07-14       Impact factor: 44.544

Review 8.  Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification.

Authors:  A López-Guillermo; J Cid; A Salar; A López; C Montalbán; J M Castrillo; M González; J M Ribera; S Brunet; J García-Conde; A Fernández de Sevilla; F Bosch; E Montserrat
Journal:  Ann Oncol       Date:  1998-08       Impact factor: 32.976

9.  Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.

Authors:  Massimo Federico; Thomas Rudiger; Monica Bellei; Bharat N Nathwani; Stefano Luminari; Bertrand Coiffier; Nancy L Harris; Elaine S Jaffe; Stefano A Pileri; Kerry J Savage; Dennis D Weisenburger; James O Armitage; Nicholas Mounier; Julie M Vose
Journal:  J Clin Oncol       Date:  2012-08-06       Impact factor: 44.544

10.  IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.

Authors:  Rob A Cairns; Javeed Iqbal; François Lemonnier; Can Kucuk; Laurence de Leval; Jean-Philippe Jais; Marie Parrens; Antoine Martin; Luc Xerri; Pierre Brousset; Li Chong Chan; Wing-Chung Chan; Philippe Gaulard; Tak W Mak
Journal:  Blood       Date:  2012-01-03       Impact factor: 25.476

View more
  26 in total

1.  RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells.

Authors:  David Vallois; Aurélie Dupuy; Francois Lemonnier; George Allen; Edoardo Missiaglia; Virginie Fataccioli; Nicolas Ortonne; Aline Clavert; Richard Delarue; Marie-Christine Rousselet; Bettina Fabiani; Francisco Llamas-Gutierrez; Seishi Ogawa; Margot Thome; Young Hyeh Ko; Keisuke Kataoka; Philippe Gaulard; Laurence de Leval
Journal:  Haematologica       Date:  2018-03-15       Impact factor: 9.941

2.  Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients.

Authors:  Camille Laurent; Bettina Fabiani; Catherine Do; Emmanuelle Tchernonog; Guillaume Cartron; Pauline Gravelle; Nadia Amara; Sandrine Malot; Maryknoll Mawanay Palisoc; Christiane Copie-Bergman; Alexandra Traverse Glehen; Marie-Christine Copin; Pierre Brousset; Stefania Pittaluga; Elaine S Jaffe; Paul Coppo
Journal:  Haematologica       Date:  2016-05-12       Impact factor: 9.941

3.  Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma.

Authors:  François Lemonnier; Violaine Safar; Asma Beldi-Ferchiou; Anne-Ségolène Cottereau; Emmanuel Bachy; Guillaume Cartron; Virginie Fataccioli; Laura Pelletier; Cyrielle Robe; Audrey Letourneau; Edoardo Missiaglia; Slim Fourati; Marie-Pierre Moles-Moreau; Alain Delmer; Reda Bouabdallah; Laurent Voillat; Stéphanie Becker; Céline Bossard; Marie Parrens; Olivier Casasnovas; Victoria Cacheux; Caroline Régny; Vincent Camus; Marie-Hélène Delfau-Larue; Michel Meignan; Laurence de Leval; Philippe Gaulard; Corinne Haioun
Journal:  Blood Adv       Date:  2021-01-26

Review 4.  T-cell Lymphoma Epidemiology: the Known and Unknown.

Authors:  Anh Phan; Rachel Veldman; Mary Jo Lechowicz
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952

5.  The Genetic Basis of Hepatosplenic T-cell Lymphoma.

Authors:  Matthew McKinney; Andrea B Moffitt; Philippe Gaulard; Marion Travert; Laurence De Leval; Alina Nicolae; Mark Raffeld; Elaine S Jaffe; Stefania Pittaluga; Liqiang Xi; Tayla Heavican; Javeed Iqbal; Karim Belhadj; Marie Helene Delfau-Larue; Virginie Fataccioli; Magdalena B Czader; Izidore S Lossos; Jennifer R Chapman-Fredricks; Kristy L Richards; Yuri Fedoriw; Sarah L Ondrejka; Eric D Hsi; Lawrence Low; Dennis Weisenburger; Wing C Chan; Neha Mehta-Shah; Steven Horwitz; Leon Bernal-Mizrachi; Christopher R Flowers; Anne W Beaven; Mayur Parihar; Lucile Baseggio; Marie Parrens; Anne Moreau; Pierre Sujobert; Monika Pilichowska; Andrew M Evens; Amy Chadburn; Rex K H Au-Yeung; Gopesh Srivastava; William W L Choi; John R Goodlad; Igor Aurer; Sandra Basic-Kinda; Randy D Gascoyne; Nicholas S Davis; Guojie Li; Jenny Zhang; Deepthi Rajagopalan; Anupama Reddy; Cassandra Love; Shawn Levy; Yuan Zhuang; Jyotishka Datta; David B Dunson; Sandeep S Davé
Journal:  Cancer Discov       Date:  2017-01-25       Impact factor: 39.397

6.  Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.

Authors:  C Laurent; A Delas; P Gaulard; C Haioun; A Moreau; L Xerri; A Traverse-Glehen; T Rousset; I Quintin-Roue; T Petrella; J F Emile; N Amara; P Rochaix; M P Chenard-Neu; A M Tasei; E Menet; H Chomarat; V Costes; L Andrac-Meyer; J F Michiels; C Chassagne-Clement; L de Leval; P Brousset; G Delsol; L Lamant
Journal:  Ann Oncol       Date:  2015-11-23       Impact factor: 32.976

7.  Clinicopathologic Features of Peripheral T-Cell Lymphoma in Sub-Saharan Africa.

Authors:  Megan J Fitzpatrick; Shahin Sayed; Zahir Moloo; Mukendi K A Kayembe; Drucilla J Roberts; Thu-Anh Pham; Liqiang Xi; Mark Raffeld; Abner Louissaint; Aliyah R Sohani
Journal:  Am J Clin Pathol       Date:  2021-06-17       Impact factor: 2.493

Review 8.  Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up.

Authors:  Francisco Vega; Catalina Amador; Amy Chadburn; Eric D Hsi; Graham Slack; L Jeffrey Medeiros; Andrew L Feldman
Journal:  Mod Pathol       Date:  2021-09-28       Impact factor: 7.842

9.  Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin.

Authors:  Maria Pamela Dobay; Francois Lemonnier; Edoardo Missiaglia; Christian Bastard; David Vallois; Jean-Philippe Jais; Laurianne Scourzic; Aurélie Dupuy; Virginie Fataccioli; Anais Pujals; Marie Parrens; Fabien Le Bras; Thérèse Rousset; Jean-Michel Picquenot; Nadine Martin; Corinne Haioun; Richard Delarue; Olivier A Bernard; Mauro Delorenzi; Laurence de Leval; Philippe Gaulard
Journal:  Haematologica       Date:  2017-01-12       Impact factor: 11.047

10.  The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development.

Authors:  François Lemonnier; Rob A Cairns; Satoshi Inoue; Wanda Y Li; Aurélie Dupuy; Sophie Broutin; Nadine Martin; Virginie Fataccioli; Romain Pelletier; Andrew Wakeham; Bryan E Snow; Laurence de Leval; Anais Pujals; Corinne Haioun; Angelo Paci; Erica R Tobin; Rohini Narayanaswamy; Katherine Yen; Shengfang Jin; Philippe Gaulard; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-12       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.